Totally agree I have shares in a number of Aust BioTecs and they are ALLWAYS long term investments . They will usually go up and down like a yo yo while ever they are not breaking even and with most it can take years . I have shares in Qbiotics (9 yrs and they are just getting to the point where their product will hit the market as a vet drug and starting level 2 FDA human trials and at that point they will float on the ASX ) GSS ( 3 yrs starting to make rapid progress towards breaking even and receiving AU , EU and US approvals . This is reflected in their current SP growth ) OSL (currently going for approval on their product , looks promising ) To many investors jump on these type of shares and are not prepared for a long journey , they can be extremly rewarding and some set you up for life .but you need to be patient . Hopefully AHZ will recover from this set back and their investors will be reap the benefits , investors are worried about the dilution of their shares but their is no other option at this point , The company needs capital to continue , with out it the shares are worth very little . I have been in similar situations before and worrying about current losses will just do your head in , Stay positive this situation can change very rapidly with a few approvals or good documented trial results
AHZ Price at posting:
13.5¢ Sentiment: None Disclosure: Not Held
(20min delay)